These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6154747)

  • 61. Age-related changes in cell surface antigens of preleukemic AKR thymocytes.
    Kawashima K; Ikeda H; Stockert E; Takahashi T; Old LJ
    J Exp Med; 1976 Jul; 144(1):193-208. PubMed ID: 180229
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Retrovirus-induced changes in major histocompatibility complex antigen expression influence susceptibility to lysis by cytotoxic T lymphocytes.
    Flyer DC; Burakoff SJ; Faller DV
    J Immunol; 1985 Oct; 135(4):2287-92. PubMed ID: 2411792
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Genetics of murine sarcoma virus (MSV)--induced tumors in AKR mice: Evidence that late progressing and early regressing tumors are controlled by different gents.
    Colombatti A; Chieco-Bianchi L; De Rossi A; D'Andrea E; Collavo D
    Int J Cancer; 1977 Apr; 19(4):565-75. PubMed ID: 66212
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Differential responsiveness to MIs locus antigens in graft-versus-host and host-versus-graft reactions.
    Wolters EA; Brons NH; van der Kwast TH; Benner R
    Cell Immunol; 1980 May; 51(2):215-25. PubMed ID: 6445232
    [No Abstract]   [Full Text] [Related]  

  • 65. Modulation of the recognition and lysis of EL4 tumor target cells by cytotoxic T lymphocytes.
    Gilmer PJ; Figard SD; Flores RV; DiRoma PJ
    Cell Immunol; 1982 Nov; 73(2):337-48. PubMed ID: 6984363
    [No Abstract]   [Full Text] [Related]  

  • 66. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
    Green WR
    J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Assignment of the gene encoding for Meth A tumour rejection antigen (TATA) to chromosome 12 of the mouse.
    Law LW
    Br J Cancer; 1984 Jul; 50(1):109-11. PubMed ID: 6743507
    [No Abstract]   [Full Text] [Related]  

  • 68. Modulation of the immune response to transplantation antigens. III. Further studies on the effects of Freund's complete adjuvant on the immune response of mice to allogeneic tumour antigen.
    Zola H
    Clin Exp Immunol; 1974 Mar; 16(3):469-79. PubMed ID: 4157121
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Genetic control of the T lymphocyte proliferative response to staphylococcal nuclease: evidence for multiple MHC-linked Ir gene control.
    Schwartz RH; Berzofsky JA; Horton CL; Schechter AN; Sachs DH
    J Immunol; 1978 May; 120(5):1741-9. PubMed ID: 307022
    [No Abstract]   [Full Text] [Related]  

  • 70. Immunological mechanisms in the pathogenesis of virus-induced murine leukemia. II. Characterization of autoreactive thymocytes.
    Proffitt MR; Hirsch MS; McKenzie IF; Gheridian B; Black PH
    Int J Cancer; 1975 Feb; 15(2):230-40. PubMed ID: 47845
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Amplified expression of murine leukemia virus (MuLV)-coded antigens on thymocytes and leukemia cells of AKR mice after infection by dualtropic (MCF) MuLV.
    O'Donnell PV; Nowinski RC; Stockert E
    Virology; 1982 Jun; 119(2):450-64. PubMed ID: 6177096
    [No Abstract]   [Full Text] [Related]  

  • 72. Cell-mediated immune reaction against tumors induced by oncornaviruses. 3. Studies by mixed lymphocyte-tumor reaction.
    Senik A; Gomard E; Plata F; Levy JP
    Int J Cancer; 1973 Jul; 12(1):233-41. PubMed ID: 4133585
    [No Abstract]   [Full Text] [Related]  

  • 73. Antigen-dependent, H-2-restricted cytolytic and noncytolytic T cell lines with specificity for minor histocompatibility antigens.
    Di Pauli R; Opalka B
    Eur J Immunol; 1982 May; 12(5):365-73. PubMed ID: 6178605
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Studies on mouse Moloney virus induced tumours: I. The detection of p30 as a cytotoxic target on murine Moloney leukaemic spleen cells, and on an in vitro Moloney sarcoma line by antibody mediated cytotoxicity.
    Epstein LB; Knight RA
    Br J Cancer; 1975 May; 31(5):499-512. PubMed ID: 50852
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Serological and immunochemical studies of H-2 allospecificities on K36, a syngeneic tumour of AKR.
    Schmidt W; Festenstein H
    J Immunogenet; 1980 Feb; 7(1):7-17. PubMed ID: 6154751
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Tumor-specific transplantation antigens of chemically induced tumors.
    Lennox ES; Sikora K
    Adv Pathobiol; 1977; (6):68-78. PubMed ID: 70987
    [No Abstract]   [Full Text] [Related]  

  • 77. Evidence for a new lymphocyte-stimulating determinant (Lsd) detected by alloreactive T cell lines.
    Opalka B; Kölsch E
    Eur J Immunol; 1983 Jan; 13(1):24-30. PubMed ID: 6601005
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Immunodominance in the T cell response to multiple non-H-2 histocompatibility antigens. IV. Partial tissue distribution and mapping of immunodominant antigens.
    Wettstein PJ; Colombo MP
    J Immunol; 1987 Oct; 139(7):2166-71. PubMed ID: 2958540
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Antigens of tumours induced by naturally occurring murine sarcoma virus (MSV-FBJ). I. Detection of group and type specific antigens by complement fixation.
    Jones DB; Moore M
    Br J Cancer; 1974 Jan; 29(1):21-30. PubMed ID: 4820943
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Major histocompatibility complex-restricted and unrestricted T helper cells recognizing minor histocompatibility antigens of B cell surfaces.
    Coutinho A; Augustin AA
    Eur J Immunol; 1980 Jul; 10(7):535-41. PubMed ID: 6157541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.